Gender Differences in Hepatitis C Virus (HCV) Treatment Outcomes With Peginterferon (pegIFN) Plus Ribavirin (RBV): An Analysis of the IDEAL Study

Kara Loubser; Eric J Lawitz; Mitchell L Shiffman; John McHutchison; Andrew J Muir; Greg Galler; Jonathan McCone; Lisa M Nyberg; William M Lee; Reem H Ghalib; Eugene R Schiff; Jianmin Long; Stephanie Noviello; Clifford A Brass; Lisa D Pedicone; Janice K Albrecht; Mark Sulkowski

doi:10.1016/S0016-5085(11)63922-X

Back

Gender Differences in Hepatitis C Virus (HCV) Treatment Outcomes With Peginterferon (pegIFN) Plus Ribavirin (RBV): An Analysis of the IDEAL Study

Journal article

Peer reviewed

Gender Differences in Hepatitis C Virus (HCV) Treatment Outcomes With Peginterferon (pegIFN) Plus Ribavirin (RBV): An Analysis of the IDEAL Study

Kara Loubser, Eric J Lawitz, Mitchell L Shiffman, John McHutchison, Andrew J Muir, Greg Galler, Jonathan McCone, Lisa M Nyberg, William M Lee, Reem H Ghalib, …

Gastroenterology (New York, N.Y. 1943), Vol.140(5), pp.S-946-S-946

2011-05

DOI: https://doi.org/10.1016/S0016-5085(11)63922-X

Metrics

8 Record Views

Details

Title: Gender Differences in Hepatitis C Virus (HCV) Treatment Outcomes With Peginterferon (pegIFN) Plus Ribavirin (RBV): An Analysis of the IDEAL Study
Creators: Kara Loubser
Eric J Lawitz
Mitchell L Shiffman
John McHutchison
Andrew J Muir
Greg Galler
Jonathan McCone
Lisa M Nyberg
William M Lee
Reem H Ghalib
Eugene R Schiff
Jianmin Long
Stephanie Noviello
Clifford A Brass
Lisa D Pedicone
Janice K Albrecht
Mark Sulkowski
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.140(5), pp.S-946-S-946
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991031598918202976